$IONS
AI 分析生成于 May 11, 2026
AI Score
Hold$IONS
Ionis Pharmaceuticals
$IONSNASDAQHealthcareMid-Cap
Ionis pioneers antisense technology to develop RNA-targeted therapeutics for serious diseases.
Market Cap
$7.0B
Revenue (TTM)
$0.8B
+5.0%
Net Income (TTM)
-$0.3B
N/A
EPS (TTM)
-$2.00
P/E Ratio
N/A
Dividend Yield
0.0%
52-Week Range
$38-$55
Beta
0.62
Dimension Scores
Fundamental
45Technical
50Sentiment
58Risk / Reward
48Momentum
58Financial Health
Profitability
50weak
Growth
61moderate
Liquidity
56strong
Solvency
47moderate
Efficiency
43moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $IONS
Free · No credit card required
免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。